My watch list
my.chemeurope.com  
Login  

High-Throughput Screening

Companies High-Throughput Screening

Chemspeed Technologies AG, Switzerland

Chemspeed is a global leader in the development of innovative instruments and consumables for scientists working in research and development laboratories including a line of fully automated parallel synthesizers, instruments for high throughput solid dispensing and liquid handling, and workstations more

Products High-Throughput Screening

Standalone Dynamic Light Scattering Detection with Cuvettes or with Plate Reader

Revolutionize your performance by transforming your conventional, batch dynamic light scattering system into the stable, automated DynaPro Plate Reader more

News High-Throughput Screening

  • ORNL chemical sampling interface features simplicity, speed

    In mere seconds, a system developed at the Department of Energy's Oak Ridge National Laboratory can identify and characterize a solid or liquid sample, providing a valuable tool with applications in material science, forensics, pharmaceuticals, biology and chemistry. The device and technique is crea more

  • Solvias opens new Corporate Location

    Just in time for the New Year, the company relocated from Basel to Kaiseraugst. The new laboratories offer more space to provide the pharmaceutical and biopharmaceutical industry with the spectrum of services that includes analysis of large and small molecules, solid-state development, and proce more

  • Scientists to produce suberabsorbents from CO2

    The Federal Ministry of Education and Research (BMBF) has pledged €2.2 million in funds for a project by the BASF-supported Catalysis Research Laboratory (CaRLa) and hte AG, a company in which BASF has a majority interest. The goal of the project, which takes place with the cooperation of research s more

White papers High-Throughput Screening

Publications High-Throughput Screening

All publications on high-throughput screening

q&more articles High-Throughput Screening

  • Big Pharma

    Developments in the pharmaceuticals industry are currently characterised by major upheavals due to the expiry of a wide range of revenue-generating products, paired with a lack of new API candidates and a burgeoning generics industry, which, riding the wave of severe cost pressures on healthcare systems, is pushing its way into the foreground of the prescription-only drugs market, with ever more far-reaching consequences. Responses to these changes in the research departments of the pharamceuticals sector are both diverse and inconsistent. more

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE